“Incorporating the 40-Gene Expression Profile (40-GEP) Test Within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s334. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2455.